Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: IN_GOD_I_TRUST who wrote (2188)	8/7/1998 5:10:00 PM
From: Scott H. Davis	Read Replies (1) \| Respond to of 4676

Steve, which biotechs get hit when is a mystery to me the last 2 months. Partially its tied to when an institution or fund reduces or closes out a position. LGND is actually slated to be marginally profitable next fiscal year. They have more items in advanced stages, but their chart is nasty also. Here's a selection - 3 biotech funds and a collection of biotechs I currently or recently followed. Warning, the following graphic is rated "N" for Nasty. quote.yahoo.com I don't understand the market's response to this sector, so I look for good points of entrycombined for good clinical progress with promising technology and go with it. Ultimately these are some long term winners. IMSCO Scott Here's some good comments underscoring the valuation disconnect. biz.yahoo.com